Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Exelixis Inc (NQ: EXEL ) 26.39 -0.03 (-0.11%) Streaming Delayed Price Updated: 3:08 PM EDT, Sep 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 884,971 Open 26.50 Bid (Size) 26.39 (7) Ask (Size) 26.40 (4) Prev. Close 26.42 Today's Range 26.17 - 26.59 52wk Range 18.64 - 27.83 Shares Outstanding 315,048,788 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News A Closer Look at 5 Analyst Recommendations For Exelixis September 18, 2024 Via Benzinga Exelixis Announces Final Results from Phase 3 Pivotal CABINET Study Evaluating Cabozantinib in Advanced Neuroendocrine Tumors Presented at ESMO 2024 and Published in New England Journal of Medicine September 16, 2024 From Exelixis, Inc. Via Business Wire Performance YTD +10.28% +10.28% 1 Month +1.97% +1.97% 3 Month +18.23% +18.23% 6 Month +11.35% +11.35% 1 Year +20.89% +20.89% More News Read More Exelixis Presents Final Overall Survival Results from Phase 3 CONTACT-02 Pivotal Study Evaluating Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Metastatic Castration-Resistant Prostate Cancer at ESMO 2024 September 15, 2024 From Exelixis, Inc. Via Business Wire NASDAQ:EXEL, an undervalued stock with good fundamentals. August 15, 2024 Via Chartmill Expert Outlook: Exelixis Through The Eyes Of 5 Analysts August 08, 2024 Via Benzinga In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals. September 06, 2024 Via Chartmill Exelixis to Webcast Fireside Chats as Part of Investor Conferences in September August 28, 2024 From Exelixis, Inc. Via Business Wire 3 Stocks to Buy for a Soft Landing, If There Is One August 15, 2024 Via MarketBeat Topics Economy Exposures Economy Interest Rates Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review August 09, 2024 Via Investor's Business Daily Analyst Sees Exelixis At Inflection Point Despite Mixed Trial Results August 07, 2024 Via Benzinga Exposures Product Safety US Stocks Set To Extend Gains Despite Mixed Earnings, VIX Dips Back Toward Pre-Sell-Off Levels: Analyst Says Pullback Is A 'Growth Scare' And Not 'Calamity' August 07, 2024 Via Benzinga Topics Stocks Exposures US Equities Exelixis (EXEL) Q2 2024 Earnings Call Transcript August 07, 2024 Via The Motley Fool Topics Earnings Exposures Financial EXEL Stock Earnings: Exelixis Beats EPS, Beats Revenue for Q2 2024 August 06, 2024 Via InvestorPlace Exelixis Announces Second Quarter 2024 Financial Results and Provides Corporate Update August 06, 2024 From Exelixis, Inc. Via Business Wire Wall Street Rebounds After Selloff, VIX Falls, Dollar Surges Against Yen: What's Driving Markets Tuesday? August 06, 2024 Via Benzinga Topics Economy Stocks Exposures Economy US Equities Exelixis Announces U.S. Food and Drug Administration (FDA) Accepted the Supplemental New Drug Application for Cabozantinib for Patients with Advanced Neuroendocrine Tumors August 06, 2024 From Exelixis, Inc. Via Business Wire US Stocks Set To Open Higher After Monday's Crash, VIX Plummets: Analyst Says Would Have Worried If Market Surged Higher Without Correction August 06, 2024 Via Benzinga Topics Stocks Exposures US Equities Exelixis to Release Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 July 23, 2024 From Exelixis, Inc. Via Business Wire In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals. July 18, 2024 Via Chartmill 7 Cheap Biotech Stocks With Major Upside Potential July 09, 2024 Via InvestorPlace When you look at NASDAQ:EXEL, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. June 27, 2024 Via Chartmill Don't overlook NASDAQ:EXEL—it's a hidden gem with strong fundamentals and an attractive price tag. June 06, 2024 Via Chartmill 10 Health Care Stocks Whale Activity In Today's Session May 31, 2024 Via Benzinga Over $8M Bet On This Health Care Stock? Check Out These 4 Stocks Insiders Are Buying May 31, 2024 Via Benzinga Exelixis to Present at the William Blair 44th Annual Growth Stock Conference May 28, 2024 From Exelixis, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
